SCHEMBL21394083

SCHEMBL21394083

c1ccc(-c2ccc(-c3ccc(-c4nc(-c5ccccc5)nc(-c5cccc6c5-c5ccccc5C6(c5ccccc5)c5ccccc5)n4)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
MAPT P10636 4/20 0.40
LMNA P02545 4/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
OPRK1 P41145 1/20 0.40
TSHR P16473 4/20 0.38
ALOX15 P16050 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
ADORA1 P30542 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
GLA P06280 1/20 0.34
PDK2 Q15119 5/20 0.33
MAPK1 P28482 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932681 1.00 MEN1 (0.40) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17932722 1.00 MEN1 (0.40) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17932738 1.00 MEN1 (0.40) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17252628 0.97 MEN1 (0.42) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17932745 0.96 MEN1 (0.37) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17932723 0.96 MAPT (0.37) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL21394084 0.95 MEN1 (0.36) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17932721 0.95 MEN1 (0.36) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL21394095 0.94 MEN1 (0.40) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL18463432 0.94 MEN1 (0.40) MEN1KMT2AMAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023027328-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2023-03-02 WO disclosed
US-11239425-B2 Organic light emitting device LG CHEM, LTD. (KR) 2022-02-01 US disclosed
US-20200388767-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-10 US disclosed
US-20190296243-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2019-09-26 US disclosed
US-20160318847-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY ACADIA PHARMACEUTICALS INC. 2016-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318847-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY SLC6A4, HTR4, GPR34 MEN1 757/4885KMT2A 4413/4885MAPT 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.